American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification
The American College of Chest Physicians published a new framework for building lung nodule programs that names validated biomarker testing, including Biodesix's Nodify Lung tests, as a core component of standardized risk stratification. The framework was developed by a multidisciplinary expert panel and presented at the 2026 CHEST Annual Meeting, the pulmonology community's largest annual gathering.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.